tiprankstipranks
Creo Medical (GB:CREO)
:CREO
UK Market
Holding GB:CREO?
Track your performance easily

Creo Medical (CREO) Technical Analysis

46 Followers

Technical Sentiment

Overall Consensus
Buy
10Bullish
6Neutral
5Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
0Bearish
Moving Average Consensus
Buy
7Bullish
0Neutral
5Bearish
Creo Medical’s (CREO) Moving Averages Convergence Divergence (MACD) indicator is 0.43, suggesting Creo Medical is a Buy.
Creo Medical’s (CREO) 20-Day exponential moving average is 18.54, while Creo Medical’s (CREO) share price is 19p, making it a Buy.
Creo Medical’s (CREO) 50-Day exponential moving average is 18.68, while Creo Medical’s (CREO) share price is 19p, making it a Buy.

Creo Medical (CREO) Pivot Points

Jan 18, 2025, 02:23 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
16.98
17.58
18.29
18.90
19.60
20.21
20.92
Fibonacci
17.58
18.09
18.39
18.90
19.40
19.71
20.21
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Creo Medical (CREO) Moving Averages

Jan 18, 2025, 02:23 PM
Period
Simple
Exponential
MA5
18.59Buy
18.87Buy
MA10
19.05Sell
18.87Buy
MA20
18.78Buy
18.54Buy
MA50
17.39Buy
18.68Buy
MA100
21.08Sell
21.08Sell
MA200
27.27Sell
26.28Sell
Creo Medical’s (CREO) 10-Day exponential moving average is 18.87, while Creo Medical’s (CREO) share price is 19p, making it a Buy.
Creo Medical’s (CREO) 100-Day exponential moving average is 21.08, while Creo Medical’s (CREO) share price is 19p, making it a Sell.
Creo Medical’s (CREO) stock price is 19p and Creo Medical’s (CREO) 50-day simple moving average is 17.39, creating a Buy signal.
Creo Medical’s (CREO) stock price is 19p and Creo Medical’s (CREO) 100-day simple moving average is 21.08, creating a Sell signal.
Creo Medical’s (CREO) stock price is 19p and Creo Medical’s (CREO) 200-day simple moving average is 27.27, creating a Sell signal.

Creo Medical (CREO) Technical Indicators

Jan 18, 2025, 02:23 PM
Name
Value
Implied Action
RSI (14)
55.32
Neutral
STOCH (9,6)
38.10
Neutral
STOCHRSI (14)
38.10
Neutral
MACD (12,26)
0.43
Buy
ADX (14)
20.47
Neutral
Williams %R
-57.14
Buy
CCI (14)
18.71
Neutral
ATR (14)
1.30
-
Ultimate Oscillator
47.05
Neutral
ROC
0.00
Sell
Creo Medical’s (CREO) Relative Strength Index (RSI) is 55.32, creating a Neutral signal.
Creo Medical’s (CREO) Trend Strength Indicator (ADX) is 20.47, creating a Neutral signal.
Creo Medical’s (CREO) Commodity Channel Index (CCI) is 18.71, creating a Neutral signal.

FAQ

Is CREO a Buy, Hold, or Sell?
Based on CREO’s technical indicators, CREO is a Buy.
    What is CREO’s RSI (14)?
    CREO’s RSI (14) is 55.32, which suggests CREO is a Neutral.
      What is CREO’s MACD?
      CREO’s MACD is 0.43, which suggests CREO is a Buy.
        What is CREO’s 5-day moving average?
        CREO’s 5-day moving average is 18.59, which suggests CREO is a Buy.
          What is CREO’s 20-day moving average?
          CREO 20-day moving average is 18.78, which suggests CREO is a Buy.
            What is CREO’s 50-day moving average?
            CREO’s 50-day moving average is 17.39, which suggests CREO is a Buy.
              What is CREO’s 200-day moving average?
              CREO’s 200-day moving average is 27.27, which suggests CREO is a Sell.
                What is CREO’s Williams % R (14)?
                CREO’s Williams % R (14) is -57.14, which suggests CREO is a Buy.
                  What is CREO’s CCI (14)?
                  CREO’s CCI (14) is 18.71, which suggests CREO is a Neutral.
                    What is the share price of Creo Medical?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis